How Long Does Ketamine Therapy Last for Depression?
Research says more about how fast ketamine can act on depression than about how long the benefit lasts. What trials found about onset, fading, relapse after a course, and maintenance.

It varies a great deal, and durability is the least settled part of the research. In trials, improvement often began within hours of a dose. After a single dose, the difference from placebo generally lasted up to about a week. After a short course of repeated treatments, many people who responded relapsed within weeks of stopping, while weekly sessions kept some responders steady for longer. How best to maintain a response is still being studied.
How fast does ketamine work for depression?
In trials, often within hours. In a 2006 placebo-controlled trial of adults with treatment-resistant depression, people given a single intravenous dose improved more than those given placebo within about two hours. In a 2013 study of repeated infusions, depression scores dropped sharply two hours after the first one.
That speed is the reason ketamine drew so much research attention. Typical antidepressants can take several weeks to act, a delay the 2006 authors described as causing considerable illness while people wait. Speed of onset, though, says nothing about how long the improvement will last.
How long does one dose of ketamine last?
Usually days, not months. In the 2006 trial, the advantage over placebo was still significant a week after the dose, but only about a third of the people treated still met the study's response criteria at that point. A 2020 meta-analysis of randomized trials found the largest effect at 24 hours, with a measurable difference lasting up to seven days after a single dose.
A Cochrane review published in 2021 rated the evidence comparing ketamine with placebo at 24 hours as very low certainty, partly because many trials gave too little detail about how treatment assignment was kept hidden from participants and raters.
How long does ketamine last after a course of treatment?
In the studies so far, often weeks rather than months once sessions stop. Three studies give a sense of the pattern:
- After up to six intravenous infusions over 12 days, half of the people who responded had relapsed within about two and a half weeks of their last infusion (median 18 days).
- In the KADS trial of twice-weekly subcutaneous ketamine, about one in five people in the flexible-dose group were in remission after four weeks. Four weeks after the last injection, fewer than one in ten were, and the difference from the control group was no longer significant.
- In a small study of older adults given subcutaneous ketamine, repeated treatments were linked with a higher chance of remission or a longer time before relapse than single treatments.
Can maintenance sessions keep the effect going?
Possibly, for some people, but the evidence is thin. In a 2019 randomized trial, participants who responded to six infusions moved on to four weekly sessions, and their symptom scores did not change during that phase. The KADS authors concluded that benefits fade after treatment stops for most patients and that ketamine should be considered as a longer-term treatment.
What nobody can yet say is how long maintenance should continue, how far apart sessions can be spaced, or what longer use means for safety. Experts convened by the American Psychiatric Association flagged how little longer-term evidence exists, and a 2018 review found that safety after repeated or long-term use had barely been assessed.
What this means for a plan at our clinic
Because durability differs so much between people, nothing about your result is assumed in advance. Typical plans here involve a series of sessions over several weeks, then a reassessment of how you have responded. Depending on that, the plan can continue, sessions can be spaced out, or treatment can stop.
It also helps to keep the rest of your care in place. If you agree, we keep your existing psychiatrist, therapist, or physician informed, so the people already caring for you can see how you are doing between sessions.
If your symptoms come back
Returning symptoms are common in the research and worth reporting early, not something to push through alone. Contact the clinic during office hours at (656) 269-4567, Monday to Friday, 9am to 5pm. If you are having thoughts of suicide or feel unsafe, call or text 988 to reach the Suicide & Crisis Lifeline at any hour, or call 911 for an emergency.
Request a consultation
A conversation, not a commitment. Please don't include medical records, diagnosis details, or anything urgent — this form is not monitored for emergencies.
In person or by telehealth
You can be seen both ways. Consultations, planning conversations, and follow-up visits happen in person at our Tampa clinic or by telehealth — whichever works better for you.
Ketamine itself is always administered in person, at the clinic, with a clinician monitoring you throughout. We do not prescribe ketamine for use at home.
Telehealth visits require you to be physically located in Florida at the time of the visit.
How telehealth works here
- Telehealth is available to patients who are physically located in Florida, and the clinicians providing that care hold active Florida licenses.
- Your location is confirmed at the start of every telehealth visit. If you are not in Florida, the visit does not go ahead.
- Ketamine is never prescribed for you to take at home. It is administered only at our clinic, in person, with a clinician monitoring you throughout — a telehealth visit does not change that.
- You are seen in person before any treatment session, because every session happens at the clinic.
- A telehealth visit never guarantees that treatment will be offered, any more than an in-person evaluation does.
- Telehealth is not for emergencies. If you are in crisis or having thoughts of self-harm, call or text 988, or call 911.
Common questions
In trials of a single intravenous dose, improvement often started within hours and the difference from placebo generally lasted up to about a week. In one early trial, only about a third of the people treated still met response criteria seven days later. That short window is why later research turned to courses of repeated sessions.
It varies, and for many people the benefit fades within weeks of stopping. In one study, half of those who responded to six infusions relapsed within about two and a half weeks. In a subcutaneous trial, remission rates fell by more than half in the four weeks after treatment ended. Some people stay well longer, but no one can predict that in advance.
No study has shown that. The research describes a treatment whose effects can be fast but often temporary, which is why researchers are still studying maintenance schedules and longer-term safety. It is best thought of as one part of ongoing care, alongside the support you already have, not as a one-time fix.
Not necessarily, and nobody can tell you that in advance. A plan can end after an initial series, continue with sessions spaced further apart, or stop early if treatment is not helping. At our clinic, the plan is reassessed after each series, and you and the clinician decide the next step together.
Sources & further reading
- A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression (Zarate et al., 2006) — Archives of General Psychiatry, via PubMed. Accessed 2026-11-02.
- Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression (Murrough et al., 2013) — Biological Psychiatry, via PubMed. Accessed 2026-11-02.
- Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials (Kryst et al., 2020) — Pharmacological Reports, via PubMed. Accessed 2026-11-02.
- Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder (Dean et al., 2021) — Cochrane Database of Systematic Reviews, via PubMed. Accessed 2026-11-02.
- Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study) (Loo et al., 2023) — British Journal of Psychiatry, via PubMed Central. Accessed 2026-11-02. Post-treatment follow-up figures are from the full text.
- Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression (George et al., 2017) — American Journal of Geriatric Psychiatry, via PubMed. Accessed 2026-11-02.
- Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial (Phillips et al., 2019) — American Journal of Psychiatry, via PubMed. Accessed 2026-11-02.
- A consensus statement on the use of ketamine in the treatment of mood disorders (Sanacora et al., 2017) — JAMA Psychiatry, via PubMed. Accessed 2026-11-02.
- Side-effects associated with ketamine use in depression: a systematic review (Short et al., 2018) — The Lancet Psychiatry, via PubMed. Accessed 2026-11-02.
- 988 Suicide & Crisis Lifeline — Substance Abuse and Mental Health Services Administration. Accessed 2026-11-02.
Links point to external organizations. Clear Ketamine Therapy does not control their content.
Reviewed by Editorial team. Last reviewed 2026-11-02. Educational information only — not medical advice or a substitute for care from your own clinicians.
Keep reading
- How Many Ketamine Sessions?There is no standard number of ketamine sessions for depression. The schedules researchers have tested, why repeated sessions are usually studied, and how a plan here is reviewed as you go.
- Does Ketamine Therapy Work?A plain summary of the research on ketamine therapy for depression: what controlled trials and reviews found, what response and remission mean, who was studied, and where the evidence runs out.
- Ketamine for DepressionKetamine therapy may be considered for some adults with depression — especially when standard treatments have not helped enough. Here is the honest picture.
- What to ExpectA plain-language walkthrough of the full treatment process at our Tampa clinic — the evaluation, the sessions themselves, and the follow-up — including the parts that vary from person to person.
Talk with our clinical team
A consultation is a conversation, not a commitment. Ask questions, share what you are comfortable sharing, and learn whether ketamine therapy may be worth considering for you.
Not for emergencies — call or text 988 or 911 if you are in crisis.
